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Abstract A wide range of equilibrium and kinetic con-
stants exist for the interaction of prothrombin and other
coagulation factors with various model membranes from a
variety of techniques. We have investigated the interac-
tion of prothrombin with pure dioleoylphosphatidylcholine
(DOPC) membranes and dioleoylphosphatidlyserine (DOPS)-
containing membranes (DOPC:DOPS, 3:1) using surface
plasmon resonance (SPR, with four different model membrane
presentations) in addition to isotheral titration calorimetry (ITC,
with suspensions of phospholipid vesicles) and ELISA
methods. Using ITC, we found a simple low-affinity interac-
tion with DOPC:DOPS membranes with a KD = 5.1 lM.
However, ELISA methods using phospholipid bound to
microtitre plates indicated a complex interaction with both
DOPC:DOPS and DOPC membranes with KD values of 20
and 58 nM, respectively. An explanation for these discrepant
results was developed from SPR studies. Using SPR with low
levels of immobilised DOPC:DOPS, a high-affinity interac-
tion with a KD of 18 nM was obtained. However, as
phospholipid and prothrombin concentrations were increased,
two distinct interactions could be discerned: (i) a kinetically
slow, high-affinity interaction with KD in the 10
-8 M range
and (ii) a kinetically rapid, low-affinity interaction with KD in
the 10-6 M range. This low affinity, rapidly equilibrating,
interaction dominated in the presence of DOPS. Detailed SPR
studies supported a heterogeneous binding model in agree-
ment with ELISA data. The binding of prothrombin with
phospholipid membranes is complex and the techniques used
to measure binding will report KD values reflecting the mix-
ture of complexes detected. Existing data suggest that the
weaker rapid interaction between prothrombin and mem-
branes is the most important in vivo when considering the
activation of prothrombin at the cell surface.
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It is generally accepted that assembly of blood coagulation
factor complexes and initiation of coagulation requires a
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phospholipid membrane surface [1, 2]. The role of the
phospholipid surface has been explained in a number of
ways: (i) enhancing the local concentrations of reactants;
(ii) inducing conformational changes and promoting opti-
mal alignment; (iii) enhancing substrate delivery and
product removal; and (iv) restricting coagulation to areas of
injury (reviewed [3]). However, the mechanism of binding
of coagulation factors to model phospholipid membranes,
let alone heterogeneous cell membranes [4], is not com-
pletely understood [5]. The vitamin K-dependent family of
membrane-binding proteins (prothrombin, and Factors VII,
IX, X, XI) involved in coagulation display c-carboxyglu-
tamic acid (Gla) residues in a highly conserved N-terminal
domain [6]. Negatively charged Gla residues bind Ca2?
ions which both maintain a conformation with an exposed
hydrophobic x-loop ready for membrane insertion, and
bridge Gla domains with anionic phospholipid, primarily
phosphatidylserine (PS), which is exposed on the external
leaflet of cell membranes following damage. In vivo, the
importance of PS exposure in maintaining haemostasis is
well recognised (reviewed [7]), and when the scrambling of
PS from inner to outer cell membrane is defective, bleeding
abnormalities can occur [8]. However, the precise struc-
tural details of the bound clotting factor optimised for
coagulation are still debated and a complete understanding
of coagulation factor–membrane binding has been further
complicated by the wide range of results obtained for
equilibrium constants published over many years in studies
using a variety of techniques with model membranes. The
importance of the kinetics of binding and enzyme activa-
tion has also been highlighted in a number of studies (e.g.
[9]).
A number of methods are available to study the binding of
peripheral membrane proteins, such as prothrombin, to
model membranes. In the present work, the interactions of
prothrombin with phospholipid were studied using a range of
complementary equilibrium and kinetic techniques, where
phospholipids are presented in a variety of common formats,
which may be more or less analogous to natural biological
membranes. Isothermal titration calorimetry (ITC) requires
no labelling of reactants and works on soluble proteins and
phospholipid suspensions, but is relatively insensitive,
requiring high concentrations of protein and well suited for
studying equilibrium constants in the 10-7–10-8 M range.
ELISA is a sensitive technique requiring only low concentra-
tions of proteins, but useful only for high-affinity interactions.
ELISA also involves manipulation and immobilisation of
phospholipid and several processing steps. The optical phe-
nomenon of surface plasmon resonance (SPR) offers several
advantages over previous methods, since it does not require
labelling of the reactants, wide ranges of ligands and analyte
concentrations can be studied, and the kinetics of binding are
observed directly in real time allowing determination of rate
constants in a straightforward manner [10]. Furthermore, a
number of different model membrane systems are available
which minimises the risk of model-specific artefacts. We have
used SPR to investigate prothrombin binding to phospholipid
presented in four forms, including a supported monolayer
prepared on an alkanethiol hydrophobic surface (HPA Sensor
Chips), immobilised phospholipid prepared on a dextran
surface via hydrophobic linkers (L1 Sensor Chips),
phospholipid vesicles tethered via incorporated biotinylated
phosphatidylethanolamine (PE) and immobilised by an anti-
biotin antibody chemically coupled to either dextran (dextran
coated CM5 and CM4 sensor chips), or to surface carboxyl
groups (C1 sensor chips). The results from kinetic studies
using SPR have been used to develop a model for prothrombin
binding to membranes that rationalises varying results
obtained in different systems and aids understanding of the
mechanisms of prothrombin activation in vivo. These
approaches are also relevant to other studies of protein–
membrane interactions. Nevertheless, it should be emphasised
that protein–membrane interactions are only one component
regulating coagulation reactions that lead to thrombin gener-
ation. Binding and processing of prothrombin by membrane–
factor Va–factor Xa (‘prothrombinase’), for example, as occur
in vivo will inevitably involve more complexities (e.g. [11])




The synthetic lipids 1,2-Dioleoyl-sn-glycerol-3-phosphocho-
line (DOPC) and 1,2-Dioleoyl-sn-glycerol-3-phospho-L-serine,
sodium salt (DOPS) were purchased from Alexis Corporation
Ltd (Nottingham, UK) or from Avanti Polar Lipids (Alabaster,
USA). Biotinylated 1,2-Dioleoyl-sn-glycero-3-phosphoetha-
nolamine (DOPE) was supplied by Avanti Polar Lipids and
polyclonal rabbit anti-biotin IgG was from Rockland Immu-
nochemicals for Research (Gilbertsville, USA). Buffers used
in these studies were buffer A (10 mM HEPES, 150 mM
NaCl, 5 mM CaCl2, pH 7.4) for experiments performed in the
presence of Ca2? ions, and buffer B (10 mM HEPES,
150 mM NaCl, 3.4 mM EDTA, pH 7.4) for experiments
performed in the absence of Ca2? ions. Prothrombin (human
and bovine) was purchased from Enzyme Research Labora-
tories (Swansea, UK) and was dialysed into buffer either A or
B before use. Prothrombin concentration was determined by
measuring the absorbance at 280 nm using E1 % = 13.6 and
molecular mass = 72 kDa. No contaminating proteins were
detected in SDS-PAGE analysis. N-octyl-ß-D-glucopyrano-
side (n-octylglucoside) was purchased from Calbiochem
Novabiochem Ltd (Nottingham, UK). Human serum albumin
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(HSA) used was a 20 % (w/v) solution from Immuno Ltd
(Vienna, Austria).
Preparation and immobilisation of phospholipid
In all the cases, vesicles were prepared prior to formation
of the phospholipid surface at a final concentration of
2 mg ml-1 as pure DOPC or DOPC:DOPS, 3:1 (25 %
DOPS). DOPC and DOPS stock solutions of 50 and
10 mg ml-1, respectively, were prepared in chloro-
form:methanol (1:1) and aliquots stored in liquid nitrogen
vapour phase. Aliquots of DOPC and DOPC:DOPS in the
appropriate ratios were dried down under a stream of
nitrogen gas and resuspended in buffer A or B, with or
without 5 mM Ca2? as appropriate. These phospholipid
suspensions were sonicated on ice/water for 5 9 30 s and
filtered using a 0.2-lm filter (Sartorius AG, Göttingen,
Germany), then extruded through a 50-nm filter (LipoFast
Extruder, Milsch Equipment Laudenbach, Germany) to
create small, unilamellar vesicles. Phospholipid vesicles
tethered via anti-biotin to CM5, CM4 and C1 sensor chips
were prepared similarly except for the inclusion of 2 % (w/v)
biotinylated DOPE.
ITC
ITC experiments were performed by Dr Alan Cooper
(Department of Chemistry, University of Glasgow, Glas-
gow, Scotland). Experiments to measure the binding of
prothrombin to DOPC or DOPC:DOPS vesicles were per-
formed at 25 C using a Microcal OMEGA titration
microcalorimeter following standard instrumental proce-
dures (Cooper and Johnson, 1994; Wiseman et al., 1989)
with a 250-ll injection syringe and 400 rpm stirring.
Samples were prepared by rigorous dialysis in buffer A and
degassed gently, immediately before use. Prothrombin
concentration in the ITC injection syringe was 0.15 mM,
and phospholipid concentration (in the ITC cell) was
2.5 mM. A typical binding experiment involved 25 9 10
ll injections of prothrombin solution into the ITC cell
(1.3 ml active volume) containing vesicles. Control
experiments were performed under identical conditions by
injection of protein into buffer alone (to correct for heats of
protein dilution). Corrected data were plotted as a binding
isotherm as the total heat energy per unit time (lcal s-1)
from each injection as determined from the area underneath
the injection peak against the molar ratio of ligand to
macromolecule. The curve was fitted by nonlinear regres-
sion using a simple single-site-binding model in the Mic-
rocal ORIGIN software package (Microcal, Northampton,
USA). For each thermal titration curve, this yields esti-
mates of the binding stoichiometry (N), the binding
constant (KA/M
-1) and the change in enthalpy of binding
(DH/kcal mol-1). The energetics of binding are expressed
by the Gibbs free energy of binding (DG).
ELISA
Two methods for immobilising phospholipid to microtitre
plates were used. In method 1, suspensions of 25 lg ml-1
phospholipids and 100 ll volumes of chrloroform:metha-
nol (1:1) were prepared and dried directly onto the surface
of the well under a stream of nitrogen gas for 1 h at 37 C.
Wells were then blocked with either buffer A or B, as
appropriate, containing 1 % (w/v) casein. Prothrombin
dilution ranges were made in either buffer A or B, as
appropriate, containing 1 mg ml-1 HSA and incubated
with immobilised phospholipid for 1 h before washing and
incubation with 5 lg ml-1 of goat anti-human prothrombin
for a further hour. In method 2, suspensions of 100 lM
phospholipids were prepared as described for ITC and SPR
work, and then incubated in microtiter plates for 1 h at
37 C. Wells were blocked and prothrombin incubated as
described above for method 1. In both methods, detection
of bound antibodies was quantified using 0.1 lg ml-1
peroxidase-conjugated rabbit anti-goat immunoglobulin.
SPR
The SPR device used for the binding studies was the Biacore-
X or Biacore 3000 instrument, and all the sensor chips were
purchased from Biacore AB (Uppsala, Sweden). Sensor chips
were treated in accordance with the manufacturer’s instruc-
tions before injection of phospholipid. Complete coverage of
HPA surfaces was assessed by injection of 10 ll of 1.5 lM
HSA at a flow rate of 10 ll min-1 and a fully coated surface
typically bound less than 30 resonance units (RU) after a
1 min injection. Vesicles were tethered to CM5, CM4 or C1
surfaces via a polyclonal rabbit anti-biotin antibody which
was coupled to the chip using standard NHS–EDC techniques
[12]. Kinetic studies were carried out using the prothrombin
concentrations given in Results using a flow rate of
20 ll min-1. Regeneration of the HPA surface was success-
fully achieved with 10 mM NaOH to remove the bound pro-
tein from the stable phospholipid monolayer or with
sequential injections of 25 mM HCl and 2 % (v/v) n-octyl-
glucoside detergent in the case of CM5, CM4 or C1 surfaces,
or 50 mM NaOH and 2 % (v/v) n-octylglucoside for L1
sensor chip surfaces to remove both phospholipid and protein.
Biomolecular interactions on the sensor chip surface are
monitored as changes in RU recorded as a sensorgram, a
plot of RU against time. Data from a reference channel of
immobilised antibody, no phospholipid, was subtracted
from the active phospholipid-bound channel where possi-
ble (CM5, CM4 and C1 surfaces). Sensorgrams were rou-
tinely analysed using the BIAevaluation 4.1 package [13]
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by global curve fitting to a complete set of curves over a
range of prothrombin concentrations, to derive values for
association rate constants (ka) and dissociation rate con-
stants (kd) and maximum binding (Rmax). Initially, a simple
1:1 Langmuir binding model was investigated, then more




ITC is commonly used to obtain thermodynamic data and
measure binding affinities for macromolecular interactions.
Affinities are calculated from the heat absorbed or released
during a binding reaction, and there is no need for labelling
or immobilisation of the reactants. However, high con-
centrations of samples are required to observe the heat
changes. In the results shown in Fig. 1 for the binding of
prothrombin to a suspension of phospholipid vesicles of
DOPC:DOPS, 3:1, protein concentrations up to 0.150 lM
were required to ensure a significant signal. However, good
data were obtained in the presence of 5 mM Ca2? ions. The
equilibrium constant, KA, from the fitting was (19.7 ±
3.8) 9 104 M-1, giving a KD value of 5.1 lM. The change
in enthalpy, DH, was -(19.6 ± 9.3) kcal mol-1 and the
calculated DG value was -7.22 kcal mol-1, indicating that
the formation of prothrombin–phospholipid complexes is
favourable. Binding to DOPC vesicles could not be studied
as the signals obtained were too weak and no binding was
observed in the absence of 5 mM Ca2? ions.
ELISA studies
Binding of prothrombin to phospholipid was also studied
using ELISA-based methodology, where phospholipid was
immobilised to microtitre plates by incubation of a vesicle
suspension or by drying phospholipid onto the plate surface
from chloroform:methanol (1:1) under a stream of nitro-
gen. Detection of bound prothrombin was the same for both
the methods and a typical example of results from such an
experiment is shown in Fig. 2 for phospholipid immobi-
lised by incubation with microtitre plates. In this case, there
was consistently better binding to DOPC:DOPS, but nev-
ertheless some observable binding to immobilised DOPC.
There was very low background binding over this range of
prothrombin in the absence of Ca2? ions, but some binding
was evident at the highest prothrombin concentrations.
Combined results from 12 independent experiments resul-
ted in apparent KD values for DOPC:DOPS, 3:1, and
DOPC surfaces of 20.3 ± 9.5 and 57.7 ± 27.1 nM,
respectively (mean ± SD). A paired t test indicated that
these two KD values were significantly different at the
0.05 % level. Data from plates where phospholipid was
dried onto the surface from solvent tended to give slightly
higher affinities. Scatchard transformations of binding
isotherms were always nonlinear, suggesting some com-
plexity in the binding mechanism; therefore, the KD values
determined represent a simple overall approximation of
binding affinity. Given the small difference in KD values
Fig. 1 Binding of prothrombin to a suspension of phospholipid
vesicles of DOPC:DOPS, 3:1, in the presence of 5 mM Ca2? at 25 C
assessed by isothermal titration calorimetry (ITC). The binding
isotherm is shown fitted to data collected for heat generated from
25 9 10 ll injections of prothrombin solution into the ITC cell. The
equilibrium constant, KA, from the fitting was (19.7 ± 3.8) 9
104 M-1, giving a KD value of 5.1 lM. The change in enthalpy,
DH, was (19.56 ± 9.26) kcal mol-1, and the calculated DG value was
-7.22 kcal mol-1
Fig. 2 Representative data for ELISA detection of prothrombin
bound to microtitre plates coated with phospholipid. A range of
prothrombin concentrations were incubated with phospholipid coated
onto microtitre plate wells, washed and bound prothormbin detected
using anti-prothrombin antibodies. Data are shown for replicate
experiments in the presence (solid symbols) or absence (open
symbols) of 5 mM Ca2?. The phospholipid surfaces used were DOPC
(circles) or DOPC;DOPS, 3:1 (squares). Single-site-binding iso-
therms were fitted and are shown as solid lines or broken lines in the
presence or absence of Ca2?, respectively
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for DOPC and DOPC:DOPS surfaces with prothrombin,
and the tendency for nonspecific binding in the absence of
Ca2? ions at high-prothrombin concentrations, it is possible
that binding is not purely dominated by phospholipid–Gla
domain interactions in these ELISA systems.
Prothrombin interaction with model membranes
studied by SPR
A number of different phospholipid surfaces were inves-
tigated by SPR. The most detailed studies involved vesicles
tethered through incorporated biotinylated DOPE to anti-
biotin antibodies chemically immobilised to the sensor chip
surface. These surfaces permit subtraction of nonspecific-
binding data from a reference channel and allow control of
the amount of phospholipid immobilised. Furthermore,
regeneration is optimised as the tethered vesicles and
membrane-bound proteins can be completely removed
from the sensor chip using detergent and acid treatment, so
that each subsequent injection of prothrombin is on a fresh
phospholipid surface. Detailed kinetic investigations were
performed on a CM5 sensor chip surface with a low level
of immobilised phospholipid, as shown in Fig. 3. This
surface was prepared by immobilising approximately 5 ng
of anti-biotin antibody which we found was able to capture
70 RU of DOPC:DOPS vesicles containing 2 % biotinyl-
ated DOPE. Immobilisation of phospholipid vesicles was
followed by injection of 50–200 nM prothrombin so that
kinetics of binding and dissociation could be followed. The
maximum capacity of prothrombin binding to this surface
was approximately 35 RU. In this case, global, simulta-
neous fitting of sensorgrams was successful using a simple
1:1 Langmuir binding model. Kinetic parameters were
ka = (2.75 ± 0.03) 9 10
5 M-1 s-1, kd = (4.98 ± 0.05) 9
10-3 s-1 and KD = 18.1 ± 0.3 nM. Data and fittings are
shown in Fig. 3. However, closer inspection focusing on the
dissociation phases indicated that two dissociation curves
were present that could be better fitted to a double expo-
nential decay (not shown). Fitting was not significantly
improved using global fitting to complex heterogeneous or
two-step models because at these low concentrations sparse
data are available from the faster kinetic dissociation phase.
There was little or no specific binding of prothrombin to
immobilised DOPC at this level of phospholipid on this
surface and no kinetic or affinity constants could be derived.
At higher concentrations of prothrombin, some nonspe-
cific binding to the dextran surface of the CM5 chip was
observed which was eliminated using a CM4 chip surface,
presumably as a result of less nonspecific binding on the less
highly charged CM4 surface. Further detailed studies using
2 ng anti-biotin antibody immobilised onto a CM4 chip
capturing vesicles-containing biotinylated PE, were per-
formed to investigate the injection of 500 nM prothrombin
for various times from 30 s to 8 min before dissociation was
monitored. The mean maximum level of phospholipid im-
mobilised over this series of injections was 94.9 ± 2.8 RU
(mean ± SD), and saturation of phospholipid binding sites
was reached after a 1 min injection of 500 nM prothrombin
achieving 35.9 ± 0.9 RU of bound prothrombin. Again,
close examination of the dissociation curves indicated dou-
ble exponential decay model fitted better, but the rate con-
stant for the rapid phase could not be reliably determined due
to limited amount of data available and the fast rate. Sig-
nificantly, there was no change in the pattern of the disso-
ciation curves over increasing injection time from 30 s to
8 min (data not shown) indicating that prothrombin binds to
heterogeneous-binding sites on DOPC:DOPS vesicles. If the
dissociation rate constant had decreased, this would have
suggested a two-step reaction mechanism where a stable
complex accumulated over time [14].
To investigate the faster dissociating complex in more
detail, other phospholipid surfaces were prepared with
higher levels of phospholipid immobilised and higher con-
centrations of prothrombin used. Phospholipid surfaces
included CM4 (1,200 RU phospholipid) and C1 (2,200 RU
phospholipid) with higher levels of anti-biotin antibody, an
L1 sensor chip which immobilises a bilayer of phospholipid
(3,000 RU phospholipid), and the HPA sensor chip that
Fig. 3 Sensorgrams showing binding kinetic of prothrombin binding
to low levels of vesicles of DOPC:DOPS, 3:1, tethered to a CM5
sensor chip in the presence of 5 mM Ca2?. The surface was prepared
by immobilising approximately 5 ng of anti-biotin antibody which
was able to capture 70 RU of phospholipid vesicles-containing 2 %
biotinylated DOPE. Immobilisation of phospholipid vesicles was
followed by injection of a 50–200 nM prothrombin and the maximum
capacity of prothrombin binding to this surface was approximately
35 RU. The surface was regenerated after each prothrombin disso-
ciation by sequential injections of 25 mM HCl and 2 % (v/v) n-
octylglucoside, which removed phospholipid and bound prothrombin,
before injection of fresh phospholipid. The solid lines show global,
simultaneous fitting of sensorgrams using a simple 1:1 Langmuir binding
model. Kinetic parameters were ka = (2.75 ± 0.03) 9 10
5 M-1 s-1,
kd = (4.98 ± 0.05) 9 10
-3 s-1 and KD = 18.1 ± 0.3 nM
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supports a phospholipid monolayer (1,300 RU phospho-
lipid). All surfaces gave essentially the same patterns of
binding, exemplified in Fig. 4a for a CM1 sensor chip
charged with 2,200 RU phospholipid. Examination of the
representative curves shown in Fig. 4a suggests that the
DOPC surface bound prothrombin with slow kinetics,
whereas the addition of DOPS to the phospholipid surface
added an additional binding component with rapid on/off
kinetics. It was not possible to adequately fit a two-site het-
erogeneous ligand model over a range of prothrombin con-
centrations (from 10 nM to 2 lM), indicating further
complexity in the binding reactions. However, using this
physiological concentration of prothrombin as shown in
Fig. 4, it was relatively straightforward to replicate the
curves in Fig. 4a and b, as shown in Fig. 4c using a hetero-
geneous ligand-binding model with rapid kinetics
(Rmax1 = 650, ka1 = 5 9 10
4 M-1 s-1, kd1 = 0.1 s
-1 and
KD = 2 lM) and with slow kinetics (Rmax2 = 200,
ka2 = 1 9 10
4 M-1 s-1, kd2 = 1 9 10
-4 s-1 andKD =
10 nM). In the presence of DOPS, both reactions take place,
but in the presence of PC only (Rmax1 has been reduced to
120) the kinetically rapid reaction is drastically reduced. A
bulk refractive index signal of 50 RU was included in all the
curves which accounts for most of the response seen with
prothrombin in the absence of Ca2? with either phospholipid
surface as shown in Fig. 4.
Discussion
Prothrombin affinity for phospholipid
Previously published estimates for KD for prothrombin
binding to PC:PS vary over a wide range from high affinity
B10-8 M range (e.g. [15–17]) to other values in the
10-7 M range or [10-6 M [18, 19]. Kinetic studies have
also provided highly variable rate constants spanning many
orders of magnitude [20, 21]. We can propose an expla-
nation for this variability based on the results obtained in
this study using different methods. Crucially, our results
using SPR differentiate between two different types of
interactions with phospholipid membranes: a rapid on–off
reaction which is apparent in the presence of DOPS-con-
taining membranes, and a slower reaction which takes
place with model membranes composed of both DOPC and
mixtures of DOPC:DOPS. The detection of complexes
from these reactions will depend on the techniques used.
For example, ELISA methods are sensitive and are able to
detect high affinity, kinetically slow interactions, since
Fig. 4 Binding of prothrombin to high levels of vesicles of DOPC or
DOPC:DOPS, 3:1, tethered to a C1 sensor chip or a CM4 sensor chip.
a shows overlaid sensorgrams for 1,100 nM prothrombin binding to
2,200 RU of phospholipid vesicles-containing 2 % biotinylated
DOPE. b shows sensorgrams for binding of 1,100 nM prothrombin
to 1,200 RU of the same phospholipid vesicles tethered to a CM4
sensor chip. The heavy lines show binding to the DOPC:DOPS, 3:1,
surface and the thinner lines show binding to the DOPC surface. Solid
lines and dashed lines show data in the presence and absence of
5 mM Ca2?, respectively. c shows simulated sensorgrams for the
same conditions generated by the BIAevaluation software used to fit
kinetic data. The heavy solid line is for the binding of 1,100 nM
prothrombin following a heterogeneous-binding model with two
components, Rmax 1 = 650 RU, kd1 = 5 9 10
4 M-1 s-1, kd1 =
0.1 s-1 and KD = 2 lM; Rmax2 = 200 RU, ka2 = 1 9 10
4 M-1 s-1,
kd2 = 0.0001 s
-1 and KD = 10 nM. The thin line is simulated
binding following the same kinetics, but Rmax1 is reduced to 120 RU.
A bulk refractive index change of 50 RU is included in all
sensorgrams and is shown as the dashed line
c
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long incubations are typically part of an ELISA protocol
allowing slow reactions to reach equilibrium, while
washing steps will remove loosely associated proteins with
fast dissociation rates. On the other hand, ITC, which
requires relatively high concentrations of prothrombin and
phospholipid, identified a binding isotherm with a KD
value & 5 lM and in line with the rapid on–off reaction
observed in the SPR work. No binding to DOPC could be
reliably detected in the absence of DOPS when using ITC.
Kinetics, mechanism and structures
SPR studies have the advantage of being able to measure
the binding over a wide range of affinities (KD of the order
10-9–10-4 M) and kinetic rate constants, and are thus useful
for exploring mechanisms of binding [10]. Both SPR and
ELISA data (Scatchard plots) discussed above support a
complex mechanism of binding where binding sites with a
range of KD values are present. Different types of interaction
such as ionic bonding involving bridging Ca2? ions, hydro-
phobic x-loop insertion into the membrane and direct inter-
actions between DOPS and prothrombin amino acid side
chains [5] could all account for the heterogeneity of binding
observed. Other complicating factors are also possible and
not considered in our basic heterogeneous model, including
association of protein molecules before and after the mem-
brane binding e.g. [15, 22, 23], and possible re-ordering of the
phospholipid around associating protein [16].
The nature and curvature of the phospholipid surface may
also affect the kinetics and equilibrium constants determined
and explain some variations seen among the different SPR
methods with immobilised vesicles (on CM5, CM4 and C1
sensor chips) or planar membranes (HPA monolayer or L1
bilayer). A SPR study on coagulation factor binding to ves-
icles tethered using cholesterol attached to DNA tags con-
cluded that membrane curvature was important for kinetics
and amount of binding, but less so for the overall equilibrium
constant (changes in association and dissociation tended to
cancel out) [17]. Interestingly, in this study [17], prothrom-
bin-binding kinetics were complicated and not analysed
fully, but the KD value with the DNA-tethered vesicles was
estimated to be 68 nM, close to our tight-binding complex.
Erb et al. [24] have also studied Gla-dependent coagulation
factor X (FX) binding to phospholipid membranes by SPR.
Again a complex binding mechanism was observed with
multiple dissociation phases, indicating multiple steps, and
also some binding to pure PC membranes was reported.
Interestingly, isolated Gla domains bound with a KD value
around 5 lM and full length FX with a KD & 40 nM, again
suggesting high-affinity binding is mediated by multiple
binding sites. Recent SPR studies using a L1 DOPC:DOPS
surface found complex binding and dissociation kinetics and
favoured a two-step mechanism arising from conformation
changes in prothrombin following membrane binding noted
in previous studies [25]. However, this is not in accord with
our SPR studies using long injections which support the
heterogeneous-binding sites model.
Several groups have worked on the structure of
phospholipid-bound Gla domains. Gla-containing clotting
factors interact in a number of distinct ways with PS head
groups leading to significant membrane insertion (up to
7 Å) of the hydrophobic x-loop exposed in the Ca2? ion-
bound prothrombin conformation [26–28]. Recent work
involving NMR, SPR and molecular dynamic simulations
suggests binding of Gla domains to PS involves one spe-
cific interaction with a single PS molecule plus other less
specific interactions with Ca2? ions bound to exposed
phosphates [29]. In this model, these phosphate groups are
provided by ‘Anything But Choline’(hence, the ‘ABC’
model). Choline has a bulky head group and sterically
hinders access to the phosphate groups in the membrane
that can chelate with Ca2? ions associated with the Gla
domains of clotting factors. Molecular dynamic simula-
tions that deal with the membrane lipid reorganisation over
long timescales that might be needed to study Gla domain–
membrane insertion are difficult to perform in fine detail
[30], but slower lipid reorganisations may explain the slow
interactions of prothrombin with PC observed in the cur-
rent study. Some previous studies have also indicated that
the kinetics of x-loop insertion might be slow and take
place in both pure PC and PCPS [31], especially where the
phospholipid has unsaturated acyl chains as in the current
study using DOPC.
Membrane binding and prothrombin activation
Direct evidence to implicate a weak prothrombin–
phospholipid interaction as important for thrombin genera-
tion comes from studies on prothrombinase activity where
prothrombin substrate delivery is separated from prothrom-
binase (FXa ? FVa) assembly [18, 32]. Higgins et al. [18]
identified a low-affinity interaction (KD = 1 lM) between
prothrombin and PCPS, which was insensitive to the phase or
fluidity of the membrane. Their conclusion was that assem-
bly of the active enzyme complex (FVa ? FXa) was sensi-
tive to membrane fluidity, but substrate, prothrombin,
binding was not. Thus, prothrombin was proposed to be
loosely associated (KD *1 lM) with the phospholipid sur-
face in a ‘shell’ [33]. This low-affinity interaction may be
optimal for substrate delivery to, and removal from, a
membrane-anchored enzyme complex such as prothrom-
binase during the propagation phase of thrombin generation
where large quantities of prothrombin need to be activated.
Several studies have proposed that FX substrate and FXa
product can be concentrated near the surface of a membrane
by exposed PS and diffuse by ‘skating’ along the membrane
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surface [34, 35]. By contrast, biophysical studies by Huang
et al. [28] concluded that prothrombin is embedded in the
membrane and moves at the same rate as phospholipid.
These authors also found a KD value of 8 lM, for pro-
thrombin fragment 1 binding to their model membranes and
highlighted complex modes of binding suggesting hetero-
geneous-binding sites or multiple binding steps. Other
models have also suggested that membrane fluidity and
hydrophobic interactions are important in promoting correct
alignment of prothrombin with Va–Xa on the membrane
surface [36]; or proposed conformational changes in pro-
thrombin resulting from membrane binding [37]. Some
kinetic models also include lower KD values for prothrom-
bin–phospholipid interactions. [7]. In conclusion, given the
importance of anionic phospholipid exposure to haemosta-
sis, the weak, fast on/off reaction observed in the presence of
DOPS is implicated in the generation of thrombin activity
in vivo. The potential importance of low-affinity interactions
(KD in the lM range) should not be overlooked, especially
for proteins available in relatively high concentrations, such
as prothrombin, which is *1.5 lM in plasma. A similar
situation applies in the case of plasminogen, a protein
involved in fibrinolysis, present in plasma at a concentration
of *2.5 lM and which binds with a KD in the lM range to
fibrin [38, 39] and cell surface receptors [40]. Whether slow,
high-affinity interactions with DOPC membranes are pos-
sible in vivo is difficult to say, but this type of interaction is
observed in a number of in vitro model membrane systems
and should be considered when data are being analysed.
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